União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresivi - prosimo, glejte dokument o izdelku.

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - linaklotid - sindrom razdražljivega črevesa - zdravila za zaprtje - constella je indicirana za simptomatsko zdravljenje zmernega do hudega sindroma razdražljivega črevesja z zaprtjem (ibs-c) pri odraslih.

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - bimatoprost - glaucoma, open-angle; ocular hypertension - prostaglandin analogues, ophthalmologicals - zmanjšanje zvišanega očesnega tlaka pri kroničnem glavkomu odprtega zakotja in očesni hipertenziji (kot monoterapija ali kot dodatno zdravljenje zaviralcev beta).

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abbvie d.o.o. - ribavirin - filmsko obložena tableta - ribavirin 400 mg / 1 tableta - ribavirin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abbvie d.o.o. - ribavirin - filmsko obložena tableta - ribavirin 600 mg / 1 tableta - ribavirin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abbvie d.o.o. - ribavirin - filmsko obložena tableta - ribavirin 200 mg / 1 tableta - ribavirin

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - deksametazon - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex je indiciran za zdravljenje odraslih bolnikov z degeneracijo edem naslednje bodisi podružnico mrežnice-vene (brvo) ali centralne mrežnice-vene (crvo). ozurdex je indiciran za zdravljenje odraslih bolnikov z vnetjem zadnji segment očesa, ki predstavljajo, kot noninfectious uveitis. ozurdex je indiciran za zdravljenje odraslih bolnikov s vida zaradi diabetično degeneracija edem (dme), ki so pseudophakic ali, ki so ovrednotena dovolj odziven, ali neprimerne za ne-kortikosteroidne terapije.

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - bimatoprost, timolol - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje intraokularnega tlaka (iop) pri bolnikih z glavkomom odprtega zakotja ali očesno hipertenzijo, ki se premalo odzivajo na topične beta blokatorje ali analoge prostaglandinov.

União Europeia - esloveno - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ritonavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - ritonavir je indiciran v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje bolnikov, okuženih s hiv-1 (odrasli in otroci, stari dve leti ali več).